Biotech and Pharmaceuticals
Walmart plans to expand its specialty HIV outreach
Shoppers wait in line at the pharmacy of a Walmart store in Charlotte, North Carolina. Callaghan O’Hare | Bloomberg | Getty Images David Rosario remembers the late 1980s with mixed emotions. He had achieved his goal of becoming a professional dancer in New York City, but in that world he also lost many young male […]
Read More
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
Narisara Nami | Moment | Getty Images A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical […]
Read More
Bernie Sanders says price of Alzheimer’s treatment is unconscionable, calls on HHS to take action
Sen. Bernie Sanders (I-VT) arrives to the U.S. Capitol Building on June 01, 2023 in Washington, DC. Anna Moneymaker | Getty Images Sen. Bernie Sanders on Wednesday called on the U.S. Health and Human Services Department to take action to ensure seniors can actually afford the expensive Alzheimer’s treatment Leqembi. Sanders, who chairs the Senate […]
Read More
This medtech stock has a ‘pathway to $1B in sales’ by 2030, Piper Sandler says
It’s time to buy Glaukos ahead of some “exciting” product launches, Piper Sandler said. Analyst Matt O’Brien upgraded Glaukos to overweight, saying investors are overlooking the potential in its treatments for glaucoma, corneal disorders and retinal diseases, namely iDose and iStent. “While the name has run in recent weeks following iDose NDA submission, we believe […]
Read More
Lawmakers worry Medicare Alzheimer’s plan won’t ensure access to new treatments
Rep. Nanette Barragan (D-CA) speaks alongside US Department of Transportation Secretary Pete Buttigieg after a tour of the Ports of Los Angeles and Long Beach during a press conference at the Port of Long Beach on January 11, 2022 in Long Beach, California. Patrick T. Fallon | AFP | Getty Images Two Democratic lawmakers are […]
Read More
This beaten-down sector could be a bright spot in commercial real estate
As the market reassesses the value of office properties, investors have been steering clear of many commercial real estate stocks. But there are some healthier spots that could be worth a second look. Greg Kuhl, a portfolio manager at Janus Henderson, said he likes the outlook for Alexandria Real Estate Equities , a pure-play owner […]
Read More
Merck sues Biden administration over Medicare drug price negotiations
Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. In a scathing complaint filed in federal district court, Merck excoriated […]
Read More
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreading
Asbe | Istock | Getty Images Moderna‘s experimental cancer vaccine, used in combination with Merck‘s Keytruda, reduced the risk of the most deadly form of skin cancer spreading to other parts of the body in a clinical trial, according to the midstage trial results published on Monday. Moderna’s cancer vaccine reduced the risk of melanoma […]
Read More
FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage
Worker labors on a production line at factory of Qilu Pharmaceutical (Hainan) Co Ltd on February 11, 2022 in Haikou, Hainan Province of China. Su Bikun | VCG | Getty Images The Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in an effort to ease an acute […]
Read More
Medicare details plan to cover Alzheimer’s treatments
An MRI scan of an Alzheimer’s patient’s brain GSO Images | Getty Images Medicare Part B will cover Alzheimer’s treatments that receive Food and Drug Administration approval, according to the federal agency that administers the program for seniors. Anyone who has Medicare Part B and meets “eligibility criteria” will be covered for new antibody treatments […]
Read More